SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ENANTA PHARMACEUTICALS INC
(NQNM:ENTA Last Sale: 51.12 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (ENTA : $51.12)
$1,018,537 million Market Cap at Market Close, July 1, 2022
Biomedics SubIndustry up .00% / Health Industry up .00% Today

Research Report Earnings Snapshot - Last 11/24/18
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


Focus is inhibitors designed for use against the hepatitis C virus, referred to as HCV. IPO at $14 March 20, 2013. Raised $56 million, selling 4 million shares, 24% of the outstanding. Lead Manager: J.P. Morgan.
Historical Charts    Technical Analysis
No Historical Data available for ENTA

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ENTA $51.12 $51.12 0 .0 $46.39 $51.13 148,903 $46.39 $51.13 19,924,426
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock #############

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex